Literature DB >> 31757879

Whole-Slide Image Analysis Reveals Quantitative Landscape of Tumor-Immune Microenvironment in Colorectal Cancers.

Seung-Yeon Yoo1,2, Hye Eun Park1,2, Jung Ho Kim1,2, Xianyu Wen2, Seorin Jeong2, Nam-Yun Cho2, Hwang Gwan Gwon3,4, Kwangsoo Kim4, Hye Seung Lee1,5, Seung-Yong Jeong6, Kyu Joo Park6, Sae-Won Han7, Tae-You Kim7, Jeong Mo Bae8,2, Gyeong Hoon Kang8,2.   

Abstract

PURPOSE: Despite the well-known prognostic value of the tumor-immune microenvironment (TIME) in colorectal cancers, objective and readily applicable methods for quantifying tumor-infiltrating lymphocytes (TIL) and the tumor-stroma ratio (TSR) are not yet available. EXPERIMENTAL
DESIGN: We established an open-source software-based analytic pipeline for quantifying TILs and the TSR from whole-slide images obtained after CD3 and CD8 IHC staining. Using a random forest classifier, the method separately quantified intraepithelial TILs (iTIL) and stromal TILs (sTIL). We applied this method to discovery and validation cohorts of 578 and 283 stage III or high-risk stage II colorectal cancers patients, respectively, who were subjected to curative surgical resection and oxlaliplatin-based adjuvant chemotherapy.
RESULTS: Automatic quantification of iTILs and sTILs showed a moderate concordance with that obtained after visual inspection by a pathologist. The K-means-based consensus clustering of 197 TIME parameters that showed robustness against interobserver variations caused colorectal cancers to be grouped into five distinctive subgroups, reminiscent of those for consensus molecular subtypes (CMS1-4 and mixed/intermediate group). In accordance with the original CMS report, the CMS4-like subgroup (cluster 4) was significantly associated with a worse 5-year relapse-free survival and proved to be an independent prognostic factor. The clinicopathologic and prognostic features of the TIME subgroups have been validated in an independent validation cohort.
CONCLUSIONS: Machine-learning-based image analysis can be useful for extracting quantitative information about the TIME, using whole-slide histopathologic images. This information can classify colorectal cancers into clinicopathologically relevant subgroups without performing a molecular analysis of the tumors. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31757879     DOI: 10.1158/1078-0432.CCR-19-1159

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  14 in total

1.  Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head-Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy.

Authors:  Ioannis M Koukourakis; Anastasia G Gkegka; Erasmia Xanthopoulou; Christos Nanos; Alexandra Giatromanolaki; Michael I Koukourakis
Journal:  Curr Oncol       Date:  2022-06-15       Impact factor: 3.109

2.  Deep learning quantified mucus-tumor ratio predicting survival of patients with colorectal cancer using whole-slide images.

Authors:  Ke Zhao; Lin Wu; Yanqi Huang; Su Yao; Zeyan Xu; Huan Lin; Huihui Wang; Yanting Liang; Yao Xu; Xin Chen; Minning Zhao; Jiaming Peng; Yuli Huang; Changhong Liang; Zhenhui Li; Yong Li; Zaiyi Liu
Journal:  Precis Clin Med       Date:  2021-01-28

Review 3.  Tumor microenvironment as a therapeutic target in cancer.

Authors:  Yi Xiao; Dihua Yu
Journal:  Pharmacol Ther       Date:  2020-11-28       Impact factor: 12.310

4.  Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran.

Authors:  Dieter Kabelitz
Journal:  Cells       Date:  2020-11-30       Impact factor: 6.600

5.  Spatial analysis of tumor-infiltrating lymphocytes in histological sections using deep learning techniques predicts survival in colorectal carcinoma.

Authors:  Hongming Xu; Yoon Jin Cha; Sung Hak Lee; Jeonghyun Kang; Tae Hyun Hwang; Jean R Clemenceau; Jinhwan Choi
Journal:  J Pathol Clin Res       Date:  2022-04-28

6.  Tumor microenvironment-adjusted prognostic implications of the KRAS mutation subtype in patients with stage III colorectal cancer treated with adjuvant FOLFOX.

Authors:  Hye Eun Park; Seung-Yeon Yoo; Nam-Yun Cho; Jeong Mo Bae; Sae-Won Han; Hye Seung Lee; Kyu Joo Park; Tae-You Kim; Gyeong Hoon Kang
Journal:  Sci Rep       Date:  2021-07-16       Impact factor: 4.379

Review 7.  HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy.

Authors:  Per Anderson; Natalia Aptsiauri; Francisco Ruiz-Cabello; Federico Garrido
Journal:  Cell Mol Immunol       Date:  2021-01-20       Impact factor: 22.096

8.  Hist-Immune signature: a prognostic factor in colorectal cancer using immunohistochemical slide image analysis.

Authors:  Ke Zhao; Zhenhui Li; Yong Li; Su Yao; Yanqi Huang; Yingyi Wang; Fang Zhang; Lin Wu; Xin Chen; Changhong Liang; Zaiyi Liu
Journal:  Oncoimmunology       Date:  2020-10-30       Impact factor: 8.110

Review 9.  Cancer immunotherapy with γδ T cells: many paths ahead of us.

Authors:  Dieter Kabelitz; Ruben Serrano; Léonce Kouakanou; Christian Peters; Shirin Kalyan
Journal:  Cell Mol Immunol       Date:  2020-07-22       Impact factor: 11.530

Review 10.  Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: Ready for Prime Time?

Authors:  Alhadi Almangush; Stijn De Keukeleire; Sylvie Rottey; Liesbeth Ferdinande; Tijl Vermassen; Ilmo Leivo; Antti A Mäkitie
Journal:  Cancers (Basel)       Date:  2022-03-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.